FDA Import Refusal SCS-8722300-8/21/1 — Kobayashi Pharmaceutical
The FDA refused shipment SCS-8722300-8/21/1 from Kobayashi Pharmaceutical (Japan) on Mar 4, 2025. The refused product falls under Drugs and Biologics — ANALGESIC, N.E.C.. Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Mar 4, 2025
- Country
- Japan
- Product Category
- Drugs and Biologics
- Product Code
- 60LAL99 ANALGESIC, N.E.C.
- Charges
- 118,3280